Concepedia

Sundar Jagannath

SJ

Statistics

Publications

433

Citations

54.8K

H-Index

108

Active since

1977

Affiliations

Dana-Farber Cancer Institute(Current)

Icahn School of Medicine at Mount Sinai

Emory University

Hackensack University Medical Center

Mount Sinai Medical Center

Sundar Jagannath is an author at Dana-Farber Cancer Institute specializing in medicine, multiple myeloma, and multiple myeloma therapy.

Publications per year

1977–2025

433

Publications

433

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

S. Vincent Rajkumar, Meletios Α. Dimopoulos, Antonio Palumbo et al. · The Lancet Oncology · 2014 · 4.9K citations · Full text

Medicine, Hematology, Internal Medicine +11

An inflammatory cytokine signature predicts COVID-19 severity and survival

Diane M. Del Valle, Seunghee Kim‐Schulze, Hsin-Hui Huang et al. · Nature Medicine · 2020 · 2.7K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

Paul G. Richardson, Bart Barlogie, James R. Berenson et al. · New England Journal of Medicine · 2003 · 2.6K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

Noopur Raje, Jesús G. Berdeja, Yi Lin et al. · New England Journal of Medicine · 2019 · 1.7K citations · Full text

Medicine, Immunology, Oncology +17

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

Jesús G. Berdeja, Deepu Madduri, Saad Z. Usmani et al. · The Lancet · 2021 · 1.7K citations

Medicine, Hematology, Oncology +17

1–5 of 433